EU orders nearly 40 million more J&J COVID vaccines
July 7, 2021Research and Development
The EU has ordered nearly 40 million more doses of the J&J COVID-19 vaccines for European countries. This is despite …
Breakthrough heart failure drug meets primary endpoint
July 7, 2021Research and Development
The Phase III trial for empagliflozin, a treatment for patients with heart failure with preserved ejection fraction, has met its …
Pfizer’s COVID-19 vaccine efficacy falls to 64% in Israel
July 6, 2021Manufacturing and Production
Israel has reported a decrease to 64% in the effectiveness of the Pfizer-BioNTech COVID-19 vaccine in preventing infections and symptomatic …
UVC light found to inactivate COVID virus in study
July 6, 2021Manufacturing and Production COVID-19, clinical trials, computer simulations, skin
A new study has found that Ultraviolet C (UVC) emitting lamps are fast, effective, and safe at inactivating SARS-CoV-2, the …
Sosei and InveniAI to collaborate on AI-powered drug discovery
July 6, 2021Manufacturing and Production
Sosei Heptares and InveniAI have entered a multi-target AI-powered and GPCR-focused drug discovery collaboration. The two companies will combine InveniAI’s …
Novel cancer therapy kick starts clinical trials
July 6, 2021Manufacturing and Production oncology
The first patient has been dosed in Phase 1/2 trials investigating a new form of cancer therapy, gamma delta TCR …
MIMETAS and Roche to collaborate on drug development
July 6, 2021Manufacturing and Production
MIMETAS and Roche have entered into a collaboration to develop human disease models to characterise novel compounds in inflammatory bowel …
Over 600,000 positive COVID tests genomically sequenced in UK
July 5, 2021Sales and Marketing COVID-19, Delta variant, UK, government, variant
The UK has genomically sequenced more than 600,000 positive COVID-19 test, it was announced on Friday. Genomic sequencing plays a …
Strawberry-flavoured tablet distributed to children with HIV
July 5, 2021Sales and Marketing
A strawberry-flavoured generic HIV drug has been distributed in Africa for children and babies living with HIV. The drug, which …
Visitors with non-EU approved jabs allowed in Madeira
July 5, 2021Sales and Marketing COVID-19, EU, Vaccine, travel
Popular holiday destination, the Portuguese islands of Madeira, have announced that they will allow visitors with any COVID-19 vaccine, even …
BioMed X and Merck launch new Oncology research programme
July 5, 2021Sales and Marketing
BioMed X and Merck have launched a new joint research programme in oncology. The new program will explore the role …
South Korea in talks to produce one billion mRNA vaccine doses
July 5, 2021Sales and Marketing
South Korea is in talks with mRNA vaccine makers, including Pfizer-BioNtech and Moderna, to produce up to one billion COVID-19 …
AstraZeneca MPO inhibitor shows promise for heart failure patients
July 2, 2021Medical Communications
Results released from AstraZeneca’s Phase IIa SATELLITE trial demonstrated that AZD4831, a myeloperoxidase (MPO) inhibitor, achieved pre-specified target engagement in …
Congenital adrenal hyperplasia treatment granted MHRA authorisation
July 2, 2021Medical Communications
The MHRA has granted marketing authorisation to Diurnal’s treatment, Efmody, as treatment of adult and adolescent patients with the rare …
J&J COVID vaccine effective against Delta variant
July 2, 2021Medical Communications
Johnson & Johnson (J&J) has reported that its single-dose Covid-19 vaccine stimulated robust, continued neutralising antibody activity against the Delta …
Travellers with Indian-made AZ jab may face European ban
July 2, 2021Medical Communications COVID-19, India, Vaccine
Up to 5 million Britons planning to travel to Europe may face a travel ban if they have been vaccinated …
Origin Group launches fully recyclable sachet for health sector
July 2, 2021Medical Communications
The Origin Group has launched a 100% recyclable single-dose sachet which is fully brandable for the health sector. The new …
CureVac vaccine shows only 48% efficacy
July 1, 2021CureVac’s COVID-19 vaccine has shown only 48% efficacy in its final analysis. This result is only marginally better than the …
Birmingham University & Nonacus to develop urine test for bladder cancer
July 1, 2021bladder cancer, cfdna, oncology
The University of Birmingham has partnered with Nonacus to develop a non-invasive test for bladder cancer. The test, which is …
Booster jabs planned for over 50s from September
July 1, 2021The NHS is planning to offer COVID-19 booster shots to over 50s from September. A third shot of the vaccine …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
